Disclosed are a medical composition comprising a monoclonal antibody or an antigen binding fragment thereof and the use thereof. The monoclonal antibody or antigen binding fragment thereof can be used as an active ingredient, specifically inhibiting or slowing down the binding of PTX3 and a PTX3 receptor, and further inhibiting or slowing down diseases or symptoms associated with the binding of PTX3 and the PTX3 receptor.